In a human neuroblastoma SH-SY5Y cell model that differentiated into dopaminergic neuron-like cells, uPA promoted neuronal differentiation under low-serum conditions, whereas PAI-1, a uPA inhibitor, suppressed this differentiation, especially under lipopolysaccharide (LPS)-induced inflammatory conditions [100]. Here, PLAU is linked to neuroblastoma.